Galderma ZO Skin Health কে অর্জন করার জন্য bargain signed করেছে,[enterprise value 1.5 billion dollar]. ZO Skin Health-এর premium, science-backed daily regimens কে Galderma-এর मौজুvarande Alastin® regenerative skincare offerings সাথে combine করলে Chikitsal-dispensed skincare portfolio strengthen habe। ZO Skin Health, Dr. Zein Obagi by founded, California의 Irvine headquarters, 40+ countries through 16,500+ physician and medical spa accounts kautta 40+ products benche। June 2026 er por last twelve months, brand approximately 330 million dollar net sales record kora ache। Galderma के CEO Flemming Ørnskov, M. D., MPH, stated the deal advances the company’s goal of building the world’s most innovative dermatology portfolio and supports long-term growth in the fast-growing medical-grade skincare segment.
Transaction is expected to be Core EPS neutral in the first full year following closing. Galderma will leverage its global scale, Integrated Dermatology Strategy, and omni-channel capabilities to support ZO Skin Health’s next phase of growth. The acquisition unites two complementary brands with strong clinical credentials and trusted positions among dermatologists and plastic surgeons. Dr. Zein Obagi expressed confidence that ZO Skin Health’s philosophy will endure and grow under Galderma’s stewardship.
উৎস: Wall Street Journal Markets · সারাংশ: HeadlinesBriefing